Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
user
  1. Dashboard
  2. My Profile
  3. My Address
  4. My Orders
  5. Acro Membership
Login Register
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP Cytokines Hot |Streptavidin（SA） Hot |Claudin 18.2 |Cadherin-17 
0
There is no goods in the shopping cart !
My Cart|Secure Checkout
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Endoglin

Endoglin

Brief Information

Name:Endoglin
Target Synonym:CD105 Antigen,CD105,END,ENG,Osler-Rendu-Weber Syndrome 1,HHT1,ORW1,Endoglin
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
ENN-H52H9 Human Human Endoglin / CD105 Protein, His Tag
ENN-H52H9-structure
ENN-H52H9-sds
ACRO Quality

Synonym Name

Endoglin,CD105,ENG,END

Background

Endoglin (ENG), endothelial glycoprotein, also known as CD105, is a coreceptor of the transforming growth factor-β (TGFβ) family signaling complex, which is highly expressed on endothelial cells and plays a key role in angiogenesis. It regulates the responses associated with binding to transforming growth factor β1 egg (Activin-A), bone morphogenetic protein 2 (BMP-2), and bone morphogenetic protein 7 (BMP-7). Endoglin may be involved in autosomal dominant disease, such as hereditary hemorrhagic telangiectasia 1 (HHT1). Circulating soluble ENG is also elevated in pulmonary arterial hypertension(PAH) and is proposed to be a biomarker for the prognosis of group I PAH patients.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Carotuximab DE-122; TRC-105; Chimeric Antibody TRC-105; NSC#754227 Phase 3 Clinical Roswell Park Cancer Institute Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung; Macular Degeneration; Neoplasm Metastasis; Carcinoma, Hepatocellular; Lung Neoplasms; Trophoblastic Tumor, Placental Site; Choriocarcinoma; Fallopian Tube Neoplasms; Glioma; Adenoma, Liver Cell; Peritoneal Neoplasms; Gliosarcoma; Ureteral Neoplasms; Astrocytoma; Sarcoma; Ovarian Neoplasms; Brain Neoplasms; Breast Neoplasms; Gestational Trophoblastic Disease; Liver Neoplasms, Experimental; Prostatic Neoplasms, Castration-Resistant; Oligodendroglioma; Small Cell Lung Carcinoma; Neoplasms; Carcinoma, Transitional Cell; Glioblastoma; Hemangiosarcoma; Trophoblastic Neoplasms; Carcinoma, Renal Cell; Solid tumours; Liver Neoplasms Details
STEMVAC EP-101 Phase 2 Clinical Epithany Triple Negative Breast Neoplasms; Breast Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
ENV-105 ENV-105 Phase 2 Clinical Kairos Pharma Ltd Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap